About this event
Following the UK government’s announcement to relax regulation of gene-edited (GE) crops to enable commercial growing in England, we will explore (i) what IP protection is available for GE crops, and (ii) the regulatory considerations on how GE crops can be marketed in food products.
What you'll learn
In part 1 delegates will learn what are the practical considerations around obtaining IP protection for your genome edited crops. This will include exploring what types of IP protection are available for new GE crops, where you can obtain these rights and what data/information you will need to make a filing for a new IP right.
In part 2, delegates will learn how to meet the expectations of food manufacturers, how GE crops should be included on food labels and how to make health and nutrition claims.
Speaker profiles
Andrea Williams is a Chartered (UK) and European Patent Attorney who works for both local and overseas clients to draft and prosecute biotechnology patent applications worldwide. She has significant experience in drafting and prosecuting applications covering new plant traits, transgenic and genome edited organisms.
Gareth Williams specialises in biotechnology-related patent work, with particular expertise in genomics and peptides. For his doctorate he conducted research into human molecular biology and genetics, which was funded as part of the Human Genome project. His patent practice includes inventions relating to therapeutic antibodies and proteins, stem cells, pharmaceutical formulations, genetically modified organisms, diagnostic and screening methods, and research tools.
Katie Vickery is a partner at Osborne Clarke specialising in regulatory compliance and risk particularly in the fields of food law, product safety, health and safety and consumer protection. She advises businesses who need to understand the regulatory framework, require an interpretation on the correct application of the law or who are being challenged by a regulator for not meeting regulatory requirements.
